Your browser doesn't support javascript.
loading
Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users.
Bond, Mary; Schoedel, Kerri A; Rabinovich-Guilatt, Laura; Gasior, Maciej; Tracewell, William; Malamut, Richard; Ma, Yuju; Webster, Lynn R.
Affiliation
  • Bond M; Teva Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
  • Schoedel KA; Altreos Research Partners, Inc., Toronto, ON, Canada.
  • Rabinovich-Guilatt L; Teva Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
  • Gasior M; Teva Pharmaceuticals, Inc., Frazer, Pennsylvania, USA.
  • Tracewell W; Teva Pharmaceuticals, Inc., West Chester, Pennsylvania, USA.
  • Malamut R; RM is a former employee of Teva Pharmaceuticals, Inc.
  • Ma Y; Teva Pharmaceuticals, Inc., Frazer, Pennsylvania, USA.
  • Webster LR; PRA Health Sciences, Salt Lake City, Utah, USA.
Pain Med ; 19(8): 1597-1612, 2018 08 01.
Article in En | MEDLINE | ID: mdl-29016880

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydrocodone / Analgesics, Opioid / Opioid-Related Disorders Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pain Med Journal subject: NEUROLOGIA / PSICOFISIOLOGIA Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydrocodone / Analgesics, Opioid / Opioid-Related Disorders Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pain Med Journal subject: NEUROLOGIA / PSICOFISIOLOGIA Year: 2018 Document type: Article Affiliation country: Country of publication: